$126 Million is the total value of Michael & Susan Dell Foundation's 7 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CCI | CROWN CASTLE INTL CORP NEW | $54,516,000 | +6.1% | 544,185 | 0.0% | 43.10% | -1.8% | |
| JPM | JPMORGAN CHASE & CO | $28,686,000 | +4.1% | 313,853 | 0.0% | 22.68% | -3.7% | |
| AET | AETNA INC NEW | $18,920,000 | +19.0% | 124,616 | 0.0% | 14.96% | +10.2% | |
| XON | INTREXON CORP | $10,428,000 | +21.5% | 432,878 | 0.0% | 8.24% | +12.5% | |
| WMB | WILLIAMS COS INC DEL | $6,824,000 | +2.3% | 225,363 | 0.0% | 5.40% | -5.2% | |
| BRKB | BERKSHIRE HATHAWAY INC DELcl b new | $6,690,000 | +1.6% | 39,500 | 0.0% | 5.29% | -5.9% | |
| ZIOP | ZIOPHARM ONCOLOGY INC | $415,000 | -1.9% | 66,749 | 0.0% | 0.33% | -9.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JPMORGAN CHASE & CO | 23 | Q3 2019 | 57.9% |
| AETNA INC NEW | 20 | Q3 2018 | 28.3% |
| INTREXON CORP | 18 | Q2 2018 | 14.6% |
| VANGUARD TAX-MANAGED INTL FD | 15 | Q3 2023 | 100.0% |
| BERKSHIRE HATHAWAY INC DEL | 14 | Q3 2019 | 13.8% |
| ZIOPHARM ONCOLOGY INC | 13 | Q2 2018 | 0.6% |
| CROWN CASTLE INTL CORP NEW | 12 | Q3 2017 | 43.9% |
| MULTIPLAN CORPORATION | 12 | Q3 2023 | 0.3% |
| MULTIPLAN CORPORATION | 8 | Q3 2022 | 26.3% |
| TIME WARNER INC | 8 | Q3 2015 | 17.6% |
View Michael & Susan Dell Foundation's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 144 | 2024-04-08 |
| 144 | 2024-03-21 |
| 13F-HR | 2024-02-14 |
| 144 | 2023-12-27 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Michael & Susan Dell Foundation's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.